HEADER TRANSCRIPTION/INHIBITOR 23-OCT-21 7VRK TITLE CRYSTAL STRUCTURE OF BRD2-BD1 IN COMPLEX WITH PURINE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: O27.1.1,REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS BET FAMILY, BET INHIBITOR, BROMODOMAIN INHIBITOR, BRD2-BD1 INHIBITOR, KEYWDS 2 TRANSCRIPTION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.PADMANABHAN,A.AROLE,P.DESHMUKH,S.ASHOK,S.MATHUR REVDAT 4 29-NOV-23 7VRK 1 REMARK REVDAT 3 16-AUG-23 7VRK 1 JRNL REVDAT 2 02-AUG-23 7VRK 1 SOURCE JRNL REMARK HELIX REVDAT 2 2 1 SCALE ATOM REVDAT 1 01-FEB-23 7VRK 0 JRNL AUTH A.H.AROLE,P.DESHMUKH,A.SRIDHAR,S.MATHUR,M.MAHALINGASWAMY, JRNL AUTH 2 H.SUBRAMANYA,N.DALAVAIKODIHALLI NANJAIAH,B.PADMANABHAN JRNL TITL STRUCTURAL AND BIOCHEMICAL INSIGHTS INTO PURINE-BASED DRUG JRNL TITL 2 MOLECULES IN HBRD2 DELINEATE A UNIQUE BINDING MODE OPENING JRNL TITL 3 NEW VISTAS IN THE DESIGN OF INHIBITORS OF THE BET FAMILY. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 79 758 2023 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 37432115 JRNL DOI 10.1107/S2059798323005211 REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 14343 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 726 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.2300 - 3.3600 0.99 2838 151 0.1663 0.2399 REMARK 3 2 3.3600 - 2.9300 1.00 2844 151 0.2146 0.2610 REMARK 3 3 2.9300 - 2.6700 0.98 2794 157 0.2233 0.2896 REMARK 3 4 2.6700 - 2.4800 0.80 2261 120 0.2286 0.3049 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.650 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.07 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 NULL REMARK 3 ANGLE : 0.944 NULL REMARK 3 CHIRALITY : 0.055 396 REMARK 3 PLANARITY : 0.007 536 REMARK 3 DIHEDRAL : 4.959 386 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7VRK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1300025048. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54056 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : RIGAKU HYPIX-6000HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14382 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 24.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.2900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.23200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 6JKE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MME 5000, 0.1M MES, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.74600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.65150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.74600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.65150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -14.33701 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 201.98882 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 69 REMARK 465 SER A 70 REMARK 465 HIS A 71 REMARK 465 MET A 72 REMARK 465 GLY A 73 REMARK 465 ARG A 74 REMARK 465 GLU A 183 REMARK 465 GLU A 184 REMARK 465 GLN A 185 REMARK 465 GLU A 186 REMARK 465 LEU A 187 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 GLY B 69 REMARK 465 SER B 70 REMARK 465 HIS B 71 REMARK 465 MET B 72 REMARK 465 GLY B 73 REMARK 465 ARG B 74 REMARK 465 VAL B 75 REMARK 465 GLU B 183 REMARK 465 GLU B 184 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 GLY C 69 REMARK 465 SER C 70 REMARK 465 HIS C 71 REMARK 465 MET C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 75 CG1 CG2 REMARK 470 GLN B 80 CG CD OE1 NE2 REMARK 470 THR C 76 OG1 CG2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 84 CD CE NZ REMARK 480 LYS A 88 CD CE NZ REMARK 480 LYS B 88 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 171 O HOH A 301 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 140 NZ LYS B 115 4547 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 110 75.13 -154.64 REMARK 500 VAL C 85 -61.18 -109.02 REMARK 500 REMARK 500 REMARK: NULL DBREF 7VRK A 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 7VRK B 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 7VRK C 73 194 UNP P25440 BRD2_HUMAN 73 194 SEQADV 7VRK GLY A 69 UNP P25440 EXPRESSION TAG SEQADV 7VRK SER A 70 UNP P25440 EXPRESSION TAG SEQADV 7VRK HIS A 71 UNP P25440 EXPRESSION TAG SEQADV 7VRK MET A 72 UNP P25440 EXPRESSION TAG SEQADV 7VRK GLY B 69 UNP P25440 EXPRESSION TAG SEQADV 7VRK SER B 70 UNP P25440 EXPRESSION TAG SEQADV 7VRK HIS B 71 UNP P25440 EXPRESSION TAG SEQADV 7VRK MET B 72 UNP P25440 EXPRESSION TAG SEQADV 7VRK GLY C 69 UNP P25440 EXPRESSION TAG SEQADV 7VRK SER C 70 UNP P25440 EXPRESSION TAG SEQADV 7VRK HIS C 71 UNP P25440 EXPRESSION TAG SEQADV 7VRK MET C 72 UNP P25440 EXPRESSION TAG SEQRES 1 A 126 GLY SER HIS MET GLY ARG VAL THR ASN GLN LEU GLN TYR SEQRES 2 A 126 LEU HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN SEQRES 3 A 126 PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS SEQRES 4 A 126 LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO SEQRES 5 A 126 MET ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN SEQRES 6 A 126 TYR TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN SEQRES 7 A 126 THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR SEQRES 8 A 126 ASP ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE SEQRES 9 A 126 PHE LEU GLN LYS VAL ALA SER MET PRO GLN GLU GLU GLN SEQRES 10 A 126 GLU LEU VAL VAL THR ILE PRO LYS ASN SEQRES 1 B 126 GLY SER HIS MET GLY ARG VAL THR ASN GLN LEU GLN TYR SEQRES 2 B 126 LEU HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN SEQRES 3 B 126 PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS SEQRES 4 B 126 LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO SEQRES 5 B 126 MET ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN SEQRES 6 B 126 TYR TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN SEQRES 7 B 126 THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR SEQRES 8 B 126 ASP ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE SEQRES 9 B 126 PHE LEU GLN LYS VAL ALA SER MET PRO GLN GLU GLU GLN SEQRES 10 B 126 GLU LEU VAL VAL THR ILE PRO LYS ASN SEQRES 1 C 126 GLY SER HIS MET GLY ARG VAL THR ASN GLN LEU GLN TYR SEQRES 2 C 126 LEU HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN SEQRES 3 C 126 PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS SEQRES 4 C 126 LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO SEQRES 5 C 126 MET ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN SEQRES 6 C 126 TYR TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN SEQRES 7 C 126 THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR SEQRES 8 C 126 ASP ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE SEQRES 9 C 126 PHE LEU GLN LYS VAL ALA SER MET PRO GLN GLU GLU GLN SEQRES 10 C 126 GLU LEU VAL VAL THR ILE PRO LYS ASN HET TEP A 201 13 HET TEP A 202 13 HET SO4 A 203 5 HET TEP B 201 13 HET TEP C 301 13 HET SO4 C 302 5 HETNAM TEP THEOPHYLLINE HETNAM SO4 SULFATE ION FORMUL 4 TEP 4(C7 H8 N4 O2) FORMUL 6 SO4 2(O4 S 2-) FORMUL 10 HOH *101(H2 O) HELIX 1 AA1 THR A 76 VAL A 85 1 10 HELIX 2 AA2 VAL A 85 LYS A 92 1 8 HELIX 3 AA3 ALA A 96 ARG A 100 5 5 HELIX 4 AA4 ASP A 112 ILE A 117 1 6 HELIX 5 AA5 ASP A 122 ASN A 132 1 11 HELIX 6 AA6 ALA A 137 ASN A 156 1 20 HELIX 7 AA7 ASP A 160 ALA A 178 1 19 HELIX 8 AA8 ASN B 77 VAL B 85 1 9 HELIX 9 AA9 VAL B 85 LYS B 92 1 8 HELIX 10 AB1 ALA B 96 ARG B 100 5 5 HELIX 11 AB2 ASP B 112 ILE B 117 1 6 HELIX 12 AB3 ASP B 122 ASN B 132 1 11 HELIX 13 AB4 ALA B 137 ASN B 156 1 20 HELIX 14 AB5 ASP B 160 SER B 179 1 20 HELIX 15 AB6 ASN C 77 VAL C 85 1 9 HELIX 16 AB7 VAL C 85 HIS C 93 1 9 HELIX 17 AB8 ALA C 96 ARG C 100 5 5 HELIX 18 AB9 ASP C 112 ILE C 117 1 6 HELIX 19 AC1 ASP C 122 ASN C 132 1 11 HELIX 20 AC2 ALA C 137 ASN C 156 1 20 HELIX 21 AC3 ASP C 160 MET C 180 1 21 CRYST1 113.492 55.303 67.499 90.00 94.06 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008811 0.000000 0.000625 0.00000 SCALE2 0.000000 0.018082 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014852 0.00000